Spearhead Capital Advisors, LLC Dexcom Inc Transaction History

Spearhead Capital Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$67.99 - $132.89 $42,017 - $82,126	-618 Closed	0 $0
Q1 2022 Apr 28, 2022	SELL	$94.08 - $130.2 $49,768 - $68,875	-529 Reduced 46.12%	618 $316,000
Q4 2021 Jan 25, 2022	BUY	$129.87 - $162.82 $259 - $325	2 Added 0.17%	1,147 $616,000
Q3 2021 Oct 27, 2021	BUY	$106.71 - $143.18 $1,173 - $1,574	11 Added 0.97%	1,145 $626,000
Q2 2021 Aug 10, 2021	BUY	$80.99 - $107.93 $9,556 - $12,735	118 Added 11.61%	1,134 $484,000
Q1 2021 Apr 28, 2021	BUY	$84.79 - $104.74 $3,561 - $4,399	42 Added 4.31%	1,016 $365,000
Q4 2020 Feb 02, 2021	BUY	$78.0 - $104.5 $2,808 - $3,762	36 Added 3.84%	974 $360,000
Q3 2020 Oct 16, 2020	BUY	$95.51 - $112.95 $4,011 - $4,743	42 Added 4.69%	938 $387,000
Q2 2020 Jul 16, 2020	BUY	$62.68 - $105.34 $7,897 - $13,272	126 Added 16.36%	896 $363,000
Q1 2020 Apr 17, 2020	BUY	$47.79 - $75.63 $36,798 - $58,235	770 New	770 $207,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Spearhead Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Spearhead Capital Advisors, LLC with notifications on news.